Scoring tool to identify patients at increased risk for drug-related problems: results of a point prevalence study at hospital admission

被引:1
|
作者
Berger, Saskia [1 ,2 ]
Hilgarth, Heike [3 ]
Fischer, Andreas [1 ]
Remane, Yvonne [4 ]
Schmitt, Jochen [2 ]
Knoth, Holger [1 ]
机构
[1] Tech Univ Dresden, Klin Apotheke, Univ Klinikum Carl Gustav Carus, Dresden, Germany
[2] Tech Univ Dresden, Zent Evidenzbasierte Gesundheitsversorgung ZEGV, Univ Klinikum Carl Gustav Carus, Dresden, Germany
[3] Bundesverband Deutsch Krankenhausapotheker eV ADKA, Berlin, Germany
[4] Univ Klinikum Leipzig, Klin Apotheke, Leipzig, Germany
关键词
Risiko Score; Arzneimittel-bezogene Probleme; Krankenhaus; Apotheker:innen; Aufnahmemanagement; MEDICATION ERRORS; PHARMACY;
D O I
10.1055/a-2161-2655
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<bold>Introduction: </bold>Drug therapy is a high-risk process and requires special attention, especially at sectoral borders. Pharmaceutical services such as medication review are appropriate measures to identify drug-related problems and thus improve the safety of drug therapy. Risk-scoring tools have been described in the literature as helpful for prioritizing medication reviews for patients at high risk for drug-related problems.<bold>Methods: </bold>In a multi-centre point prevalence study, we identified patients at increased risk for medication-related problems at hospital admission using the medication risk tool. In addition, the current level of implementation of pharmacy services was surveyed.<bold>Results: </bold>A total of 11 (58%; 11/19) hospital pharmacies in Saxony participated in the point prevalence survey. The scoring tool identified 32% (279/875) of patients at increased risk for medication-related problems (Meris score >12 group) at admission. Thereby, the number of drugs in the Meris score >12 group was 10.6 (average; standard deviation 3.5; n=279), while in the Meris score <= 12 group it was only five drugs per patient (average 4.6; standard deviation 2.8; n=596). The age of patients in the Meris score >12 group averaged 75.9 +/- 11 years, while the age of patients in the Meris score <= 12 group averaged 60.6 +/- 17.9 years.<bold>Discussion: </bold>Prioritization with the help of a risk-scoring tool is essential as pharmacy services in Saxon hospitals still need to be regularly established and in order to identify patients with an increased risk for drug-related problems at an early stage.
引用
收藏
页码:E113 / E119
页数:7
相关论文
共 50 条
  • [41] A Prospective Study on Hospitalization due to Drug-related Problems in a Tertiary Care Hospital
    Konuru, Venkateswarlu
    Naveena, Bodanam
    Reddy, Edulakanti Sneha
    Vivek, Bandela Charles
    Shravani, Gyadari
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2019, 11 (04): : 328 - 332
  • [42] Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
    Abdela, Ousman Abubeker
    Bhagavathula, Akshaya Srikanth
    Getachew, Henok
    Kelifa, Yohannes
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2016, 8 (04): : 289 - 295
  • [43] Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
    Kaufmann, Carole P.
    Stampfli, Dominik
    Mory, Nadine
    Hersberger, Kurt E.
    Lampert, Markus L.
    BMJ OPEN, 2018, 8 (03):
  • [44] The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals
    Hege Salvesen Blix
    Kirsten K. Viktil
    Åsmund Reikvam
    Tron Anders Moger
    Bodil Jahren Hjemaas
    Piia Pretsch
    Tine Flindt Vraalsen
    Elspeth K. Walseth
    European Journal of Clinical Pharmacology, 2004, 60 : 651 - 658
  • [45] Drug-related problems reported by patients with rheumatic diseases: an observational study
    Lex L. Haegens
    Victor J. B. Huiskes
    Elisabeth M. Smale
    Charlotte L. Bekker
    Bart J. F. van den Bemt
    BMC Rheumatology, 7
  • [46] The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals
    Blix, HS
    Viktil, KK
    Reikvam, A
    Moger, TA
    Hjemaas, BJ
    Pretsch, P
    Vraalsen, TF
    Walseth, EK
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (09) : 651 - 658
  • [47] Electronic screening of medical records to detect patients at risk of drug-related problems
    Roten, Isabelle
    Marty, Stefan
    Beney, Johnny
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 290 - 290
  • [48] Drug-related problems reported by patients with rheumatic diseases: an observational study
    Haegens, Lex L.
    Huiskes, Victor J. B.
    Smale, Elisabeth M.
    Bekker, Charlotte L.
    van den Bemt, Bart J. F.
    BMC RHEUMATOLOGY, 2023, 7 (01)
  • [49] Prevalence, Clinical Profile, and Preventability of Drug-Related Hospital Admissions: Prospective Observational Study
    Ashcroft, Darren M.
    Kongkaew, Chuenjid
    Williams, Steven
    Metcalfe, David
    Mandal, Jaydeep
    Noyce, Peter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S121 - S121
  • [50] External validation of the Medication Risk Score in polypharmacy patients in general practice: A tool for prioritizing patients at greatest risk of potential drug-related problems
    Hoj, Kirsten
    Pedersen, Henrik Schou
    Lundberg, Anne Sofie Baymler
    Bro, Flemming
    Nielsen, Lars Peter
    Saedder, Eva Aggerholm
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 129 (04) : 319 - 331